High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$28.4M
$28,427,467
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $5,125,647Whalex12 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $5,127,273Whalex17 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $4,921,275Largex20 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-03-06 | $102,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $4,537,853Largex13 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$4,010,187Largex9
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $4,010,187Largex9 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $4,603,232Largex9 | S | Form 4 |